Regeneron Ventures

Venture capital firm
Greenwich, Connecticut, USA$479M AUMwww.regeneronventures.comSee connections →

Strategy

Geographies
Greenwich, Connecticut, USA

Recent changes

  1. Aug 11, 2026Invested in Infinimmune (Series A, $75M) Business Wire (via FinancialContent)

Portfolio

2 total

Recent Investment Activity

1

Track record: led 1 and participated in 0 of 1 tracked venture round · 1 in the last 12 months · led 1 Series A

DateCompanyEventRoleAmountValuationInvestorsSource
Aug 11, 2026InfinimmuneSeries ALed$75M—Pulse story

Co-Investors

12

Similar Firms

overlapping sector, stage or region

Value Add Research

Latest Pulse

  1. City Therapeutics Prices Upsized $200M IPO At $18City Therapeutics priced its upsized IPO at $18 a share for about $200 million in gross proceeds, above the terms Pulse covered in early October, with Nasdaq trading under ticker CTY starting October 16.→
  2. Infinimmune Raises $75M for Human-Derived Antibody DrugsInfinimmune raised a $75 million Series A co-led by Regeneron Ventures and Playground Global to advance two atopic dermatitis antibody candidates built from its human-derived Anthrobody platform.→

Regeneron Ventures FAQ

What companies has Regeneron Ventures invested in?

Regeneron Ventures' portfolio includes Infinimmune, Iambic.

Who does Regeneron Ventures co-invest with most?

In the rounds Value Add tracks, Regeneron Ventures most often invests alongside Abingworth (1 shared deal), ARK Invest (1 shared deal), Ascenta Capital (1 shared deal), Catalio Capital Management (1 shared deal), Civilization Ventures (1 shared deal).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction